cell growth, differentiation and cell death. We have developed a protein-based therapeutic approach to target the pump in cancer cells centered on a novel molecular mechanism for regulation ... treatments that increase…
study objective was to evaluate primary care providers’ (PCP) responses to SCPs developed for breast and colorectal cancer survivors in their practice and to determine whether PCP response
deletion and mitochondrial enzyme activities during the development of human AD. Mitochondrial DNA damage also leads to other pathologies, including colorectal cancer in liver metastasis, and malignant brain cancers…
immune response by targeting antigens that are over-expressed by tumour cells. Furthermore, prostate cancer develops slowly and this could be used to the advantage of clinicians by giving them ... more opportunities to…
identifying proteins informative for features of clinical relevance to cancer patients. To obtain proteome data, we developed a large format system for two-dimensional difference gel electrophoresis and an application…
Most anticancer drugs are not specific to cancer cells. As a result, the formulation development of delivery systems containing anticancer agents capable of targeting tumor cells is highly desired
regulated during embryonic development, with one transcript been expressed during early stages of lung development (embryonic isoform) and the other transcript been expressed at later stages and in adult lung…
attack tumor cells. In other words, activating the immune system to treat cancer through the development of an immunogenic living drug. Among the main methods, the sgRNA of the target ... results can be helpful in the…
second most common cancer in the UK and the most common cancer in males. The aetiology of PC is poorly understood and the molecular events that underpin the disease ... number of studies have been aimed at the genetic…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.